Iximab 100Mg Inj (Infixmab)
Iximab 100mg Injection contains Infliximab, a biologic medicine used to treat chronic inflammatory conditions such as rheumatoid arthritis, Crohn's disease, and plaque psoriasis.
Imported medicine — supplied under DRAP NOC. Arranged on demand through the No Objection Certificate process of the Drug Regulatory Authority of Pakistan, only for patients with a valid prescription who complete identity verification. Non-returnable once dispensed. Learn more about NOC orders →
Overview
Iximab 100mg Injection is a prescription biologic medication containing the active ingredient Infliximab. It is used to treat several chronic, autoimmune inflammatory conditions, including rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and severe plaque psoriasis. By targeting specific proteins in the body, Iximab helps reduce inflammation and manage long-term symptoms.
Important Information
Prescription medicine: Iximab is supplied only against a valid prescription from a registered doctor. Use it only as directed by your doctor.
NOC medicine: Iximab is only available to patients willing to complete identity verification and the NOC (No Objection Certificate) process. It is arranged on demand against a valid prescription.
Key Benefits of Iximab
Reduces joint pain, swelling, and stiffness in patients with rheumatoid arthritis.
Helps induce and maintain clinical remission in moderate to severe Crohn's disease.
Improves mucosal healing and reduces symptoms in ulcerative colitis.
Decreases spinal inflammation and improves physical function in ankylosing spondylitis.
Clears skin lesions and reduces scaling in patients with moderate to severe plaque psoriasis.
Iximab Ingredients and Usage
Iximab contains Infliximab, which belongs to a class of medications known as monoclonal antibodies or tumor necrosis factor (TNF) blockers. It is prescribed for adults and pediatric patients with moderate to severe active Crohn's disease or ulcerative colitis who have not responded well to conventional therapies.
It is also indicated for reducing signs and symptoms, inhibiting the progression of structural damage, and improving physical function in patients with moderately to severely active rheumatoid arthritis, when used in combination with methotrexate.
Additionally, Iximab is used to treat active ankylosing spondylitis, active psoriatic arthritis, and chronic severe plaque psoriasis in patients who are candidates for systemic therapy.
How Does Iximab Work?
Infliximab works by binding specifically to tumor necrosis factor-alpha (TNF-alpha), a naturally occurring cytokine in the body that promotes inflammation. In patients with autoimmune diseases, the body produces too much TNF-alpha, leading to healthy tissue damage and chronic inflammation.
By blocking the action of TNF-alpha, Iximab helps lower the inflammatory response, which reduces joint damage, heals intestinal linings, and clears skin plaques associated with autoimmune disorders.
How to Use Iximab
Iximab 100mg is administered as an intravenous (IV) infusion by a qualified healthcare professional in a clinical or hospital setting.
The infusion is given slowly over a period of time, and patients are monitored closely during and after the procedure for any signs of infusion reactions.
Your doctor will determine the appropriate treatment schedule and duration based on your specific medical condition and response to the therapy.
Iximab Side Effects
Like all biologic medicines, Iximab can cause side effects, although not everyone experiences them. Please inform your healthcare provider immediately if you notice any new, unusual, or worsening symptoms during your treatment.
Headache
Nausea and abdominal pain
Infusion-related reactions
Upper respiratory tract infections
Sinusitis
Fever or chills
Skin rash or itching
Fatigue
Warnings
Iximab can lower your body's ability to fight infections, increasing the risk of serious bacterial, viral, or fungal infections.
Patients must be screened for latent tuberculosis (TB) before starting treatment, as active TB can develop during therapy.
There is an increased risk of developing certain types of cancers, including lymphoma, particularly in adolescent and young adult patients.
This medicine may worsen congestive heart failure, so patients with pre-existing heart conditions must be monitored closely.
Hepatitis B virus reactivation can occur in patients who are chronic carriers of this virus.
Precautions and Who Should Avoid It
Inform your doctor if you have a history of chronic or recurring infections, tuberculosis, or exposure to anyone with tuberculosis.
Tell your healthcare provider if you have a history of heart failure, nervous system disorders like multiple sclerosis, or cancer.
Consult your doctor before receiving any vaccinations, as live vaccines should not be given while using this medication.
If you are pregnant, planning to become pregnant, or breastfeeding, discuss the potential risks and benefits with your specialist before starting treatment.
Drug and Food Interactions
Concurrent use of Iximab with other biologic medicines, such as anakinra or abatacept, is not recommended due to an increased risk of serious infections.
Live vaccines should not be administered concurrently with this medication as they may cause infections.
Inform your doctor about all other immunosuppressive medications, such as corticosteroids or methotrexate, that you are currently taking.
Customer Reviews
No reviews yet. Be the first to review this product!
Login to write a review
